98%
921
2 minutes
20
The objective of this study was to evaluate the effects of yeast products () and essential oils () in total or partial replacement to in-feed antibiotic protocols (growth promoter and prophylactic), both in recommended doses and in overdose of prophylactic antibiotics (), on growth performance, and diarrhea incidence in the growing-finishing pigs; and fecal microbiota in market hogs. Four hundred pigs (20.36 ± 2.64 kg) were assigned to five treatments in a randomized block design: diets with prophylactic and growth promoter antibiotics (); ANT with 30% more PA (); diets with less PA and YP (); diets with less PA, YP and EO (); and antibiotics-free diets with YP and EO (). The content of the active components of the YP was 60% purified β-1,3/1,6-glucans extracted from yeast (Macrogard), 20% functional water-soluble MOS (HyperGen), and 18% MOS, extracted from yeast (ActiveMOS). From 0 to 14 d, pigs of the ANT+30, ANT+Y, and ANT+Y+EO treatments showed a greater body weight () and average daily gain () compared to pigs from the Y+EO group. From 14 to 35 d, pigs of ANT+30 and ANT+Y+EO treatments were heavier than Y+EO group. At 105 d, ANT pigs had a higher BW than the Y+EO group. For the entire period, ADG of ANT pigs was greater, and feed conversion ratio better than Y+EO pigs. From 0 to 35 d, pigs of the Y+EO treatment showed a higher diarrhea incidence compared to pigs of the other groups. From 49 to 70 d, ANT+Y and ANT+Y+EO treatments showed a lower diarrhea incidence than Y+EO group, which remained the case during the overall period. At 105 d, the alpha diversity of fecal microbiota by Shannon Entropy was lower in ANT, ANT+30, and Y+EO groups than observed for ANT+Y+EO group. The abundance of phylum and ratio was higher in ANT than in ANT+Y+EO pigs. phylum abundance in ANT+Y+EO was higher than ANT, ANT+Y, and Y+EO. family abundance was higher in ANT, ANT+30, and ANT+Y groups than in ANT+Y+EO and Y+EO groups. ANT+Y+EO and Y+EO groups show a lower abundance of genus than ANT and ANT+30 groups. In conclusion, the use of YP and EO, in partial replacement to the in-feed antibiotic protocols, does not reduce the growth performance, can replace antibiotic growth promotors, and reduce the in-feed use of PA in growing-finishing pigs. The use of YP and EO, together with PA, increases the microbial diversity, despite having important genera for weight gain in less abundance. Overdose of PA does not improve growth performance and reduces microbial diversity, which does not characterize it as an efficient preventive protocol.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11344245 | PMC |
http://dx.doi.org/10.1093/tas/txae104 | DOI Listing |
Nat Med
August 2025
Eli Lilly and Company, Indianapolis, IN, USA.
Relaxin is a peptide hormone that may decrease circulatory congestion and improve kidney function. In this study, we conducted a double-blind, international, multicenter trial to test whether volenrelaxin, a long-acting form of human relaxin, can improve left atrial (LA) function, reduce congestion and improve kidney function in patients with heart failure and preserved ejection fraction (HFpEF). We randomly assigned patients with New York Heart Association (NYHA) class II-IV HFpEF and recent heart failure (HF) decompensation to 25-mg, 50-mg or 100-mg volenrelaxin or placebo administered subcutaneously once weekly.
View Article and Find Full Text PDFNat Commun
August 2025
Else Kroener Fresenius Center for Digital Health, Technical University Dresden, Dresden, Germany.
Although surgical resection is the standard therapy for stage II/III colorectal cancer, recurrence rates exceed 30%. Circulating tumor DNA (ctNDA) detects molecular residual disease (MRD), but lacks spatial and tumor microenvironment information. Here, we develop a deep learning (DL) model to predict disease-free survival from hematoxylin & eosin stained whole slide images in stage II-IV colorectal cancer.
View Article and Find Full Text PDFFoods
July 2025
Postharvest and Refrigeration Group, Department of Agricultural Engineering and Institute of Plant Biotechnology, Universidad Politécnica de Cartagena, 30203 Cartagena, Murcia, Spain.
This research analyzes the innovative development of carnauba wax coatings enriched with essential oils (EOs: lemon, orange, grapefruit, clove, oregano, and cinnamon) or fruit by-products (FBPs: avocado, tomato, carrot, orange, lemon, and grapefruit) to improve postharvest preservation of organic oranges and lemons. Six EOs and six FBPs were evaluated for total phenolic content (TPC) and in vitro antifungal activity against . Based on results, grapefruit, oregano, and clove EOs were selected for lemons, while avocado, orange, and grapefruit FBPs were selected for oranges.
View Article and Find Full Text PDFAlzheimers Dement (N Y)
August 2025
Introduction: The Health and Aging Brain Study-Health Disparities (HABS-HD) is an ongoing prospective study aimed at understanding brain health and aging. The current work provides a description of the cohort baseline characteristics and outlines the study methodology.
Methods: We analyzed available data from = 1066 non-Hispanic Black (NHB), = 1425 Hispanic, and = 1349 non-Hispanic White (NHW) partners who were actively enrolled in HABS-HD.
Stroke
August 2025
Department of Neurology, Western University, Hamilton, Ontario, Canada (L.A.S., S.F.).
Background: Insertable cardiac monitoring (ICM) detects atrial fibrillation (AF) in substantial proportions of cryptogenic stroke, noncryptogenic ischemic stroke without known AF, and nonstroke patients who are at risk of underlying AF. Given differences in patient characteristics across studies, there may be differences in AF detection rates on ICM across these subgroups that have not been identified. We investigate whether AF detection rates on ICM are higher in cryptogenic stroke or transient ischemic attack (C-IS/TIA) patients compared with individuals with noncryptogenic stroke or without stroke, when accounting for differences in study populations.
View Article and Find Full Text PDF